Login to Your Account

$50M Up Front for Phase I Compound

Acceleron, Celgene in Potential $1.8B Bone Loss Collaboration

By Jennifer Boggs

Thursday, February 21, 2008
When it came to signing its first biotech collaboration since being founded in 2003, Acceleron Pharma Inc. made sure it was a big one. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription